Investment Rating - The investment rating for the company is "Accumulate" (maintained) [5] Core Views - The company's performance is expected to continue recovering driven by growth in the defense business, with potential in new fields such as quantum technology and instrumentation [5][6] - The company is projected to achieve net profits of 100 million, 145 million, and 172 million yuan for the years 2025, 2026, and 2027 respectively, corresponding to PE ratios of 63.1, 43.7, and 36.9 times at the current stock price [6] Financial Performance Summary - For the first three quarters of 2025, the company achieved revenue of 652 million yuan (up 17% year-on-year) and a net profit of 55.93 million yuan (up 55% year-on-year) [9] - In Q3 2025, revenue reached 243 million yuan (up 35% year-on-year and up 11% quarter-on-quarter), with a net profit of 18.75 million yuan (up 698% year-on-year but down 24% quarter-on-quarter) [9] - The company’s revenue and profitability showed significant recovery in Q3 2025, benefiting from improved demand in the defense sector [9] Business Outlook - The company is focusing on strategic emerging industries, with a strong foundation provided by the recovery of defense orders [9] - The company is actively expanding into quantum communication, medical, low-altitude economy, and intelligent connected vehicles, which are expected to drive future business growth [9] - The company maintains a high R&D expense ratio of 9%, with significant investment in defense-related new product development [9]
富士达（920640）：防务业务增长驱动业绩持续修复，量子技术、仪器装备等新领域潜力可期